Hypermethylation Test Guides Lynch Syndrome Care: Megan Hoenig, M.S., M.P.H., CGC
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Megan Hoenig, M.S., M.P.H., CGC, explains how Mayo Clinic Laboratories' unique hypermethylation analysis (Mayo ID: MLHPB) provides critical adjunct information for managing Lynch syndrome. That genetic condition increases patients' risk for many kinds of cancer.
Speaker 3: (00:32)
Could you provide our listeners with a little bit about yourself and your background?
Speaker 3: (01:27)
Could you give an overview of our MLH1 hypermethylation, also referred to as MLHPB in our test catalog?
Speaker 3: (02:48)
Can you talk about why your team thought it was really important to develop this test?
Speaker 3: (04:03)
What patients would this testing really benefit?
Speaker 3: (06:10)
How are the results used in patient care?
Speaker 3: (07:56)
Anything else you would like our listeners to hear about MLHPB?